Andrew Bellinger - Net Worth and Insider Trading

Andrew Bellinger Net Worth

The estimated net worth of Andrew Bellinger is at least $42,624 dollars as of 2024-11-13. Andrew Bellinger is the CSO & CMO of Verve Therapeutics Inc and owns about 6,629 shares of Verve Therapeutics Inc (VERV) stock worth over $42,624. Details can be seen in Andrew Bellinger's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew Bellinger has not made any transactions after 2022-12-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Andrew Bellinger

To

Andrew Bellinger Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Andrew Bellinger owns 1 companies in total, including Verve Therapeutics Inc (VERV) .

Click here to see the complete history of Andrew Bellinger’s form 4 insider trades.

Insider Ownership Summary of Andrew Bellinger

Ticker Comapny Transaction Date Type of Owner
VERV Verve Therapeutics Inc 2022-12-01 Chief Scientific Officer

Andrew Bellinger Latest Holdings Summary

Andrew Bellinger currently owns a total of 1 stock. Andrew Bellinger owns 6,629 shares of Verve Therapeutics Inc (VERV) as of December 1, 2022, with a value of $42,624.

Latest Holdings of Andrew Bellinger

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
VERV Verve Therapeutics Inc 2022-12-01 6,629 6.43 42,624

Holding Weightings of Andrew Bellinger


Andrew Bellinger Form 4 Trading Tracker

According to the SEC Form 4 filings, Andrew Bellinger has made a total of 6 transactions in Verve Therapeutics Inc (VERV) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Verve Therapeutics Inc is the sale of 865 shares on December 1, 2022, which brought Andrew Bellinger around $19,852.

Insider Trading History of Andrew Bellinger

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Andrew Bellinger Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Andrew Bellinger Ownership Network

Ownership Network List of Andrew Bellinger

No Data

Ownership Network Relation of Andrew Bellinger

Insider Network Chart

Andrew Bellinger Owned Company Details

What does Verve Therapeutics Inc do?

Who are the key executives at Verve Therapeutics Inc?

Andrew Bellinger is the Chief Scientific Officer of Verve Therapeutics Inc. Other key executives at Verve Therapeutics Inc include See Remarks Andrew D. Ashe , Chief Administrative Officer Joan Nickerson , and director & 10 percent owner Krishna Yeshwant .

Verve Therapeutics Inc (VERV) Insider Trades Summary

Over the past 18 months, Andrew Bellinger made no insider transaction in Verve Therapeutics Inc (VERV). Other recent insider transactions involving Verve Therapeutics Inc (VERV) include a net purchase of 1,800,000 shares made by Krishna Yeshwant , a net purchase of 76,000 shares made by Andrew D. Ashe , and a net sale of 1,514 shares made by Joan Nickerson .

In summary, during the past 3 months, insiders sold 0 shares of Verve Therapeutics Inc (VERV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,068 shares of Verve Therapeutics Inc (VERV) were sold and 1,876,000 shares were bought by its insiders, resulting in a net purchase of 1,873,932 shares.

Verve Therapeutics Inc (VERV)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Verve Therapeutics Inc Insider Transactions

No Available Data

Andrew Bellinger Mailing Address

Above is the net worth, insider trading, and ownership report for Andrew Bellinger. You might contact Andrew Bellinger via mailing address: 500 Technology Square, Cambridge Ma 02139.